{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:41:27Z","timestamp":1779399687421,"version":"3.53.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.diabres.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T19:43:34Z","timestamp":1462045414000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Increased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitors"],"prefix":"10.1016","volume":"119","author":[{"given":"Naomi S.","family":"Levitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasheeta","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisela","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle V.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2016.03.012_b0005","doi-asserted-by":"crossref","first-page":"1690S","DOI":"10.3945\/ajcn.111.019075","article-title":"Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings-insights from South Africa","volume":"94","author":"Levitt","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2016.03.012_b0010","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","article-title":"Diabetes in sub-Saharan Africa","volume":"375","author":"Mbanya","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2016.03.012_b0015","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0140-6736(12)61814-5","article-title":"Health in South Africa: changes and challenges since 2009","volume":"380","author":"Mayosi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2016.03.012_b0020","article-title":"Overview of the current state of the epidemic","volume":"1\u201311","author":"Hankins","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.diabres.2016.03.012_b0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1230413","article-title":"Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment","volume":"339","author":"Bor","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.diabres.2016.03.012_b0030","article-title":"New insights on diabetes mellitus and obesity in Africa-part 1: prevalence, pathogenesis and comorbidities","author":"Kengne","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2016.03.012_b0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pcad.2013.10.014","article-title":"Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa","volume":"56","author":"Mensah","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2016.03.012_b0040","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jacc.2009.05.055","article-title":"Cardiovascular disease in adult and pediatric HIV\/AIDS","volume":"54","author":"McDonald","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2016.03.012_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157016206775197664","article-title":"Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection","volume":"4","author":"Barbaro","year":"2006","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.diabres.2016.03.012_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/QCO.0b013e328320a849","article-title":"Cardiovascular disease and HIV infection: host, virus, or drugs?","volume":"22","author":"Martinez","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.diabres.2016.03.012_b0055","first-page":"58","article-title":"The incidence of cardiovascular disease, cancer and type 2 diabetes comorbidities in HIV infection: a systematic review","volume":"3","author":"Nigatu","year":"2013","journal-title":"J Nurs Educ Pract"},{"key":"10.1016\/j.diabres.2016.03.012_b0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/QAI.0b013e318221863f","article-title":"Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients","volume":"57","author":"Dave","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.diabres.2016.03.012_b0065","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/ije\/dyt198","article-title":"Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis","volume":"42","author":"Dillon","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.diabres.2016.03.012_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043336","article-title":"Rising diabetes prevalence among urban-dwelling black South Africans","volume":"7","author":"Peer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2016.03.012_b0080","series-title":"Surveillance of risk factors for non-communicable disease: the WHO STEP-wise approach","author":"Bonita","year":"2002"},{"key":"10.1016\/j.diabres.2016.03.012_b0085","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.diabres.2016.03.012_b0090","series-title":"Obesity: preventing and managing the global epidemic: report of a WHO consultation","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.diabres.2016.03.012_b0095","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2011-0246","article-title":"Preservation of beta-cell function: the key to diabetes prevention","volume":"96","author":"DeFronzo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2016.03.012_b0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11892-013-0369-9","article-title":"Diabetes and HIV: current understanding and future perspectives","volume":"13","author":"Kalra","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.diabres.2016.03.012_b0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/QAI.0b013e31818ceaa4","article-title":"Cardiovascular complications in HIV management: past, present, and future","volume":"50","author":"Aberg","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.diabres.2016.03.012_b0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QAI.0b013e31819c291b","article-title":"Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy","volume":"50","author":"Samaras","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.diabres.2016.03.012_b0115","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabres.2016.03.012_b0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","article-title":"HIV infection: epidemiology, pathogenesis, treatment, and prevention","volume":"384","author":"Maartens","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2016.03.012_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-6405-10-32","article-title":"Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects","volume":"10","author":"Paula","year":"2013","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.diabres.2016.03.012_b0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/590154","article-title":"No impairment of endothelial function or insulin sensitivity with 4weeks of the HIV protease inhibitors atazanavir or lopinavir\u2013ritonavir in healthy subjects without HIV infection: a placebo-controlled trial","volume":"47","author":"Dube","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2016.03.012_b0135","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(13)70271-8","article-title":"Metabolic disease in HIV infection","volume":"13","author":"Lake","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diabres.2016.03.012_b0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11904-012-0124-x","article-title":"The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care","volume":"9","author":"Samaras","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.diabres.2016.03.012_b0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.transproceed.2010.09.098","article-title":"Epidemiology and costs of diabetes","volume":"43","author":"Bruno","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.diabres.2016.03.012_b0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1468-1293.2008.00687.x","article-title":"Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study","volume":"10","author":"Lo","year":"2009","journal-title":"HIV Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716300377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716300377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:22:38Z","timestamp":1536754958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822716300377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":29,"alternative-id":["S0168822716300377"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.03.012","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}